Open Government Portal
Health Canada reviewed the potential risk of impotence (erectile dysfunction) with the use of oral retinoids because of a publication …
A Health Canada safety review was carried out as a follow-up assessment on the potential risk of retinal detachment with …
In 2014, Health Canada completed a first safety review for the Omnipod because a high number of complaints, reporting high …
After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly …
Health Canada carried out a safety review to investigate the potential risk of developing an abnormal heart rhythm (QT interval …
Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction …
Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared …
Health Canada reviewed the potential risk of acute kidney injury with the use of levetiracetam, because of an article that …
A safety review was carried out to evaluate the potential risk of Raynaud's phenomenon in patients taking Intuniv XR. Raynaud's …
As part of Health Canada's ongoing monitoring of glistening development in IOLs, Health Canada reviewed the available safety information related …